Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

A woman's liver problems improved after she stopped taking spironolactone.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

The document concludes that early diagnosis of Balint's syndrome is crucial for effective treatment and that understanding drug interactions, like between ritonavir and statins, is important for patient care.

Women with PCOS have lower self-esteem and body image satisfaction.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

A wearable device using electric stimulation can significantly improve hair growth.

Hair follicle regeneration may slow tumor growth.

Type 2 diabetes does not change how metformin works in obese pregnant women, so dosage adjustments are not needed.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

Nanoemulgel is a promising method for delivering drugs, especially for those that don't dissolve well in water.

PBX1 reduces aging and cell death in stem cells by boosting SIRT1 and lowering PARP1.

The conclusion is that modifying scalp lifting surgery by cutting one occipital artery and making other changes reduces complications and improves outcomes for patients with severe hair loss.

Nanostructured lipid carriers are effective for treating hyperpigmentation in women aged 30-40.

The document concludes that non-endocrine alopecia in pets varies in treatment effectiveness and often has a poor prognosis, especially in cats.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

A mother's diet at conception can cause lasting genetic changes in her child.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.